Leading Pharma Biotech Sees Significant Stock Surge Amid Blockchain Acquisition Plans

According to BlockBeats, shares of Hong Kong-listed company Leading Pharma Biotech (HK0399) surged over 10% during trading, with the current transaction volume reported at 8 million Hong Kong dollars. The company recently announced its intention to acquire the entire equity of blockchain project Conflux, aiming to expand its presence in the blockchain sector. Two founding members of Conflux are currently serving as executive directors at Leading Pharma Biotech.